MedTrace Logo

Impact of PharmaTE Trial on Glycemic Control, Diabetes Knowledge, Medication Adherence and Quality of Life in Type 2 Diabetes Patients: A Mixed-Method Study Protocol

NCT07043816 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 154

Last updated 2026-04-29

No results posted yet for this study

Summary

The goal of this clinical trial is to find out whether a pharmacist-led tele-educational program (PharmaTE trial) can help people with type 2 diabetes manage their condition better.

The main questions this study aims to answer are:

1. Does the PharmaTE trial improve blood sugar control (HbA1c levels)?
2. Does it help patients better understand their condition?
3. Does it increase how well patients follow their medication schedule?
4. Does it improve the quality of life for patients with type 2 diabetes?
5. Is this type of tele-education program feasible and acceptable for patients?

Participants will:

Be randomly placed into one of two groups:

Intervention group: Receive five virtual education sessions with a clinical pharmacist over the phone or via Zoom (each lasting 20-30 minutes), in addition to their usual diabetes care.

Control group: Continue receiving standard diabetes care from their healthcare team without the additional pharmacist-led sessions.

Complete assessments at the beginning and end of the study. These include:

A blood test for HbA1c

, Questionnaires on diabetes knowledge, medication adherence, and quality of life

Some participants in the intervention group will be invited for interviews after the sessions to share their experiences and opinions about the program.

Who can join? Adults aged 18-65 with uncontrolled type 2 diabetes (HbA1c \> 7%), receiving care at Ibrahim Bin Hamad Obaidullah Hospital in Ras Al-Khaimah, who speak Arabic and can provide consent.

Conditions

  • Type 2 Diabetes (T2DM)
  • Glycemic Control
  • Diabetes Knowledge
  • Medication Adherence
  • Quality of Life

Interventions

BEHAVIORAL

PharmaTE Trial

In addition to standard care, patients in the PharmaTE trial interventional group will receive tele-education led by a clinical pharmacist who has completed a training course and is certified as a diabetes educator. The tele-education program is comprised of five individualized educational sessions, each lasting approximately 20-30minutes and held at two-month intervals. These sessions are conducted via Zoom or telephone based on patient preference. Before the beginning of each session, participants will receive a reminder message along with the Zoom meeting invitation link about the session, covering various educational topics related to diabetes management. Additionally, after each session, patients will receive a brochure summarizing what has been discussed.

Sponsors & Collaborators

  • Universiti Sains Malaysia

    collaborator OTHER

  • Rabia Hussain

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2027-08-30
Completion
2027-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07043816 on ClinicalTrials.gov